Drawing for Serial No. 79252979

USPTO serial 79252979

Serial No. 79252979

Reviewed by CopyMark Law Group

Reg. 5837048Status 739Registered
Filing date
Status date
Registration date
Aug 20, 2019
Examiner
ABRAMS, JACQUELINE WILLETTE
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with Serial No. 79252979?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005[ Anti-infectives; ] anti-inflammatories; [ antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system; [ pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; ] pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, [ the endocrine system, ] * and * the musculo-skeletal system [ and the genitourinary system ] ; [ pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; ] pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders [ ; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 2, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 10, 2026ES7RTEAS SECTION 7 REQUEST RECEIVED—
Sep 3, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Aug 10, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Aug 10, 2026INPCINVALIDATION PROCESSED—
Jan 7, 2026INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 7, 2025NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
May 7, 2025C75AREGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.—
May 6, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Jan 13, 2025ES75TEAS SECTION 71 & 15 RECEIVED—
Aug 20, 2024REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Jan 3, 2020FINVFINAL DECISION TRANSACTION PROCESSED BY IB—
Dec 14, 2019FICSFINAL DISPOSITION NOTICE SENT TO IB—
Dec 13, 2019FIMPFINAL DISPOSITION PROCESSED—
Nov 20, 2019FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 20, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jun 4, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jun 4, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 15, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Apr 26, 2019ALIEASSIGNED TO LIE—
Apr 16, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Apr 6, 2019RFNTREFUSAL PROCESSED BY IB—
Mar 27, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 27, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 27, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Mar 25, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Mar 21, 2019RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 21, 2019RFRRREFUSAL PROCESSED BY MPU—
Mar 12, 2019RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 12, 2019MAFRAPPLICATION FILING RECEIPT MAILED—
Mar 11, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2019DOCKASSIGNED TO EXAMINER—
Mar 7, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 6, 2019LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Feb 28, 2019REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance